Instinct Bio Technical Company Holdings (BIOT) closed at $0.20 on October 22, 2026, down 8.3% from the previous close, on volume of 111,946 shares (30-day average 482,851).
Data as of October 22, 2026.
No headlines found.
Globe Newswire (Fri, 4-Sep 7:00 AM ET)
Globe Newswire (Mon, 10-Aug 7:00 AM ET)
Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications. The company also develops regenerative products for skin healing, hydration, and elasticity.
Instinct Bio Technical Company Holdings trades on the NASDAQ stock market under the symbol BIOT.
As of October 22, 2026, BIOT stock price declined to $0.20 with 111,946 million shares trading.
BIOT has a beta of -10.33, meaning it tends to be less sensitive to market movements. BIOT has a correlation of 0.02 to the broad based SPY ETF.
BIOT has a market cap of $5.89 million. This is considered a Sub-Micro Cap stock.
BIOT support price is $.20 and resistance is $.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOT shares will trade within this expected range on the day.
